Literature DB >> 13912880

[Resistance of P. falciparum to the action of chloroquine (preliminary note)].

J da SILVA, P F LOPES, L F FERREIRA, R MORTEO, J B NAVEIRA.   

Abstract

Entities:  

Keywords:  CHLOROQUINE/therapy; MALARIA/therapy

Mesh：

Substances：

Year:  1961        PMID： 13912880

Source DB:  PubMed          Journal:  Hospital (Rio J)        ISSN： 0018-5469


× No keyword cloud information.
  5 in total

1.  A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.

Authors:  J M de Souza; U K Sheth; R M de Oliveira; A T Gomes; E Q Cavalcante
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.

Authors:  J M de Souza; U K Sheth; R M de Oliveira; H Roulet; S D de Souza
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  A phase I clinical trial of mefloquine in Brazilian male subjects.

Authors:  J M de Souza
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

4.  A phase II clinical trial of mefloquine in Brazilian male subjects.

Authors:  J M de Souza
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

5.  Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area.

Authors:  Bianca Ervatti Gama; Natália K Almeida de Oliveira; Mariano G Zalis; José Maria de Souza; Fátima Santos; Cláudio Tadeu Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2009-07-14       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.